68

Shanghai Aladdin Biochemical Technology Co. Ltd. A

688179 · SHG · Basic Materials / Chemicals

14.73CNY-0.65 (-4.23%)

Price History

Full chart

Market Stats

Previous Close15.38
Open15.38
Day Range14.63 – 15.48
52-Week Range11.81 – 31.56
Volume10.04M
Market Cap8.18B
P/E (TTM)53.71
Forward P/E0.00
EPS0.42
Dividend Yield0.62%
Beta0.63
50-Day Avg20.22
200-Day Avg19.22

About

Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents and laboratory consumables primarily under Aladdin and i-quip brands in China and internationally. It offers chemistry and biochemical reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and stable isotopes; material science solutions for energy, electronic, and biomedical materials; and small molecules, such as compound libraries, ligand families, antibody-drug conjugates, and protein degradation-targeting chimeras, as well as classification by signaling pathway, target toxin, and disease. The company also provides life sciences comprising protein, antibody, and molecular, protein, and cell biology; GMP-grade products, which include bioactive small molecules, grade protein, upstream process chemicals, downstream process and formulation chemicals, and culture medium and buffer raw materials. In addition, it offers laboratory equipment, such as miscellaneous tools; tweezers, scrapers, and tools; PCR supplies and equipment; balance, scale, and weighing tools; sealing film, foil, and tape; filtration and chromatography; microscope slides; liquid handling and dispensing; sample processing; glassware; and safety, gloves, eyeglasses, and cleaning products. The company sells its reagents products under the Aladdin brand and its experimental consumables under the Core Silicon Valley brand through its e-commerce platform. Its products are used in analytical chemistry, chemical synthesis, materials science and engineering, biopharmaceutical production, drug discovery, and genomics applications. The company was founded in 2008 and is based in Shanghai, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEOMr. Jiuzhen Xu
  • Employees831
  • HeadquartersSouth Tower, Shanghai, China, 201206, China
  • Websitehttps://www.aladdin-e.com

Leadership

  • Mr. Jiuzhen XuChairman of the Board & GM · b. 1966
  • Mr. Gu WeiyuCFO, Deputy GM & Director · b. 1975
  • Mr. Shen HonghaoAccounting Supervisor & Director · b. 1983
  • Mr. Xinan ZhaoDirector, Deputy GM & Secretary of Board of Directors · b. 1969

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue209.60M234.22M287.66M378.10M402.88M533.56M695.72M
Growth (%)-+11.74%+22.82%+31.44%+6.55%+32.44%+30.39%
Cost of Revenue61.23M91.86M108.56M156.33M160.36M194.44M250.62M
Gross Profit148.37M142.36M179.10M221.78M242.51M339.12M445.10M
Gross Margin70.79%60.78%62.26%58.65%60.20%63.56%63.98%
Operating Expense71.61M55.97M84.31M120.34M146.66M198.33M258.77M
Operating Income76.76M86.39M94.79M101.44M95.85M140.79M186.33M
Operating Margin36.62%36.88%32.95%26.83%23.79%26.39%26.78%
EBITDA81.73M94.72M114.94M129.79M130.31M172.95M217.55M
EBITDA Margin38.99%40.44%39.96%34.33%32.34%32.41%31.27%
Net Income63.69M74.43M89.36M92.77M85.83M98.76M102.06M
Net Income Margin30.39%31.78%31.06%24.54%21.30%18.51%14.67%
R&D15.72M15.68M22.66M38.93M51.25M62.86M76.91M
R&D as % of Total Revenue7.50%6.70%7.88%10.30%12.72%11.78%11.06%
Interest Expense188.96K242.32K407.70K4.67M6.69M7.29M27.43M
Interest Expense % of Total Revenue0.09%0.10%0.14%1.24%1.66%1.37%3.94%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets390.59M863.55M932.10M1.48B1.51B1.78B2.66B
Total Liabilities44.41M46.85M73.79M504.03M469.15M635.25M1.49B
Total Equity346.18M816.70M858.32M974.80M1.04B1.07B969.31M
Cash83.58M340.06M349.18M570.71M522.54M466.80M697.43M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow56.19M81.39M15.00M-43.26M55.79M151.52M400.57M
Capital Expenditure6.24M9.10M113.38M61.97M45.68M35.52M49.00M
Free Cash Flow49.95M72.29M-98.38M-105.23M10.11M115.99M351.57M
Dividends Paid41.82M41.88M50.56M40.38M35.38M62.94M70.46M
FCF to OCF88.90%88.81%-655.88%243.24%18.12%76.56%87.77%
Dividend Paid to FCF83.72%57.94%-51.39%-38.37%350.05%54.26%20.04%

Earnings

Report DateFeb 23, 2021Apr 26, 2021Aug 24, 2021Oct 27, 2021Mar 3, 2022Apr 25, 2022Aug 22, 2022Oct 30, 2022Feb 27, 2023Apr 25, 2023
EPS Estimate----------
EPS Actual0.190.140.150.130.210.220.140.110.180.12
Surprise----------
TimingPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap8.18B
Enterprise Value8.49B
Trailing P/E53.71
Forward P/E0.00
Price / Sales10.32
Price / Book6.49
EPS0.42
Book Value3.79
Revenue (TTM)791.54M
Gross Profit (TTM)506.92M
EBITDA230.03M
Profit Margin17.88%
Operating Margin24.21%
Return on Equity13.45%
Return on Assets5.80%
Shares Outstanding362.77M
Shares Float207.81M
Beta0.63
Dividend Yield0.62%
Dividend Rate0.14
Payout Ratio33.33%

Dividends

20262×
0.07Jul 2, 20260.07Jan 19, 2026
20252×
0.10Jun 5, 20250.08Feb 26, 2025
20241×
0.25May 21, 2024
20231×
0.15Jul 7, 2023
20221×
0.17May 26, 2022
20211×
0.15May 31, 2021

Stock Splits

  • Jun 5, 20251.2:1
  • May 21, 20241.4:1
  • Jul 7, 20231.4:1
  • May 26, 20221.4:1